MedTrace Logo

Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant

NCT01660347 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2025-05-02

No results posted yet for this study

Summary

This clinical trial studies how well donor stem cell boost works in treating patients with low blood cells after donor stem cell transplant. Donor stem cell boost may increase low blood cell counts caused by hematologic cancer or its treatment.

Conditions

Interventions

BIOLOGICAL

Allogeneic hematopoietic stem cell transplantation

Undergo allogeneic PBSCT boost using the CliniMACS CD34 Reagent System

BIOLOGICAL

Peripheral blood stem cell transplantation

Undergo allogeneic PBSCT boost using the CliniMACS CD34 Reagent System

PROCEDURE

Management of therapy complications

Undergo allogeneic PBSCT boost using the CliniMACS CD34 Reagent System

Sponsors & Collaborators

  • Sidney Kimmel Cancer Center at Thomas Jefferson University

    lead OTHER

Principal Investigators

  • Dolores Grosso, DNP, CRNP · Thomas Jefferson University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2014-12-31
Completion
2014-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01660347 on ClinicalTrials.gov